Slynd and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Slynd (drospirenone), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Adderall, and have Cataplexy.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Slynd. It is created by eHealthMe based on reports of 1,600 people who have side effects when taking Slynd from the FDA, and is updated regularly.

What is Slynd?

Slynd has active ingredients of drospirenone. It is often used in birth control. eHealthMe is studying from 1,658 Slynd users. Check the latest studies of Slynd.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,748 drugs and 2,913 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

On Jul, 14, 2026

1,600 people reported to have side effects when taking Slynd.
Among them, 16 people (1.0%) have Hypersensitivity.

Among these 16 people:

How long have people been on Slynd when they have Hypersensitivity? *

What is the gender of people who have Hypersensitivity when taking Slynd? *

female: 100 %
male: 0.0 %

What is the age of people who have Hypersensitivity when taking Slynd? *

What are other drugs people take besides Slynd? *

What are other side effects people have besides Hypersensitivity? *

Headache (pain in head): 6 people, 37.50%
Urticaria (rash of round, red welts on the skin that itch intensely): 4 people, 25.00%
Inflammation: 3 people, 18.75%
Sluggishness (lacking alertness): 3 people, 18.75%
Asthma Exercise Induced: 3 people, 18.75%
Fatigue (feeling of tiredness): 3 people, 18.75%
Feeling Abnormal: 3 people, 18.75%
Heart Rate Irregular: 3 people, 18.75%
Muscle Aches (muscle pain): 3 people, 18.75%
Itching: 2 people, 12.50%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 31.25%
Drowsiness: 5 people, 31.25%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 31.25%
Stress And Anxiety: 3 people, 18.75%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 18.75%
Muscle Spasms (muscle contraction): 3 people, 18.75%
Migraine (headache): 3 people, 18.75%
Dizziness: 3 people, 18.75%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 18.75%
Acne Cystic (skin problems that cause pimples): 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Slynd and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Slynd:

Slynd (1,658 reports)

Hypersensitivity treatments and more:

Hypersensitivity (272,618 reports)

Browse all side effects of Slynd:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,748 drugs)

Browse all the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,913 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on drospirenone (the active ingredients of Slynd) and Slynd (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.